Fosrenol will be a new phosphate binder for dialysis patients
December 2004
Fosrenol will be a new phosphate binder for dialysis patients.
It's an alternative to PhosLo, Renagel, AlternaGel, etc.
Phosphate increases in the blood as kidney function declines. This leads to hypocalcemia and secondary hyperparathyroidism.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote